The drug-eluting stent market is anticipated to grow at a CAGR of 8.20% from US$11.499 billion in 2025 to US$17.049 billion ...

It is quite clear that the Gujarat government’s rather ill-informed decision will penalise Indian manufacturers who today hold over 73% of the domestic market and export over 5 lakh stents annually to ...

Drug-eluting stents reduce the occurrence of in-stent restenosis and the need for subsequent target vessel revascularization when compared with bare-metal stents. However, drug-eluting stents may ...

Heimann Gutters shares expert insight into how professional gutter installs help Okanagan homeowners avoid common pitfalls ...

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has received FDA approval to move forward with its Virtue Trial ...

Senior consultant interventional cardiologist at Apollo Main hospitals in Chennai Dr Y Vijayachandra Reddy said that highly ...

The global market for Peripheral Artery Disease (PAD) treatments has been witnessing significant growth, with the market size valued at $3,524.77 million in 2019. It is projected to escalate to $5,715 ...

We value keeping the Device Guide up to date.

Orchestra BioMed (Nasdaq:OBIO) announced that it received FDA investigational device exemption (IDE) for its Virtue ...

SNS Insider Report Forecasts 9.58% CAGR Growth from 2024–2032 as Minimally Invasive Procedures and Technological Advancements Propel Market Expansion.Austin, May 02, 2025 (GLOBE NEWSWIRE) -- Pediatric ...

DelveInsight's Balloon Catheter Market Insights report provides the current and forecast market analysis, individual leading Balloon Catheter Companies market shares, challenges, Balloon Catheter ...